The Pancreatic Cyst Surveillance Program focuses on the comprehensive and multidisciplinary evaluation and treatment of patients diagnosed with cystic lesions in the pancreas. The goal of the program is to identify patients who require further diagnostic studies, immediate therapeutic interventions or long term surveillance. This program is devoted solely to patients with IPMN (intraductal papillary mucinous neoplasm), MCN (mucinous cystic neoplasm) or pancreatic cysts.
IPMNs are cysts that form in the pancreas. These lesions have the potential to evolve into pancreatic cancers. At the Pancreatic Cyst Surveillance Program, our gastroenterologists bring highly specialized knowledge to the diagnosis and management of these cysts.
Each patient is initially seen in a joint clinic staffed by expert gastroenterologists and surgeons. Subsequently, the patient is discussed in our weekly conference, where a plan is formulated by a team of interventional endoscopists, surgeons and oncologists. This multidisciplinary approach assures that an evidence-based and rational approach to every patient and clinical condition is followed. Each plan is tailored to meet each patient's specific needs. A plan can involve annual or semi-annual intervals of imaging and endoscopy, or possible surgery.
By offering a practice that monitors patients with known precursors to this disease, we strive to take a positive step towards fighting pancreatic cancer.
Conditions We Treat
- Intraductal papillary mucinous neoplasm (IPMN)
- Mucinous Cystic Neoplasm
- Serous Cystadenoma
- Endoscopic Ultrasound
- Fine Needle Aspiration
- Fine Needle Injection
- Confocal Endomicroscopy of Pancreatic Cysts
- Endoscopic Cyst- or Pseudocystgastrosomy
- Comprehensive pancreatic surgery program